How do you choose between using inebilizumab and rituximab for patients with NMOSD?

Does recent published data (Xu et al) change your decision making?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

When should patients be referred for advanced MRI testing to assess for CVS and PRL?

How do you decide on the next therapy for post-ICI triple M syndrome (myositis/myocarditis/myasthenia) after steroids, PLEX, and IVIG?

When do you find FDG-PET/CT helpful in the workup for autoimmune encephalitis?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
TrialMatch
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.